Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Accuracy of Vacuum-assisted Breast Biopsy Elite 10G Versus BARD 14G Core Needle Biopsy of Abnormal Breast Lesions.

NCT04612439 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT04612439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04612439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Accuracy of Vacuum-assisted Breast Biopsy Elite 10G Versus BARD 14G Core Needle Biopsy of Abnormal Breast Lesions.
Lead sponsor
Fudan University
Phase
Phase 3
Overall status
Unknown status
Start date
November 1, 2020
Completion date
June 30, 2022
Enrollment
1,470 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer